This study aimed to determine the antitumor effect of CAPE and evaluate the potential molecular mechanisms of CAPE on the expression of GDF15 and its downstream genes, NDRG1 and maspin, in human bladder carcinoma cells. This evidence concerns the gene NDRG1 and urinary bladder carcinoma.